%PDF-1.4
%
45 0 obj
<>
endobj
42 0 obj
<>
endobj
103 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-03-05T12:03:47Z
2024-03-28T18:17:28-07:00
QuarkXPressª 4.11: AdobePS 8.6 (219)
2024-03-28T18:17:28-07:00
application/pdf
Heather
2002-183.april
uuid:1dd3b18f-1dd2-11b2-0a00-b70827bd3700
uuid:1dd3b191-1dd2-11b2-0a00-5b0000000000
endstream
endobj
31 0 obj
<>
endobj
32 0 obj
<>
endobj
46 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
10 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
13 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
16 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
19 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
133 0 obj
[137 0 R]
endobj
134 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.2213 Tw 7.76 0 0 8 54 714.5293 Tm
[(Hiroshi Fukazawa, MD, )17.7 (T)69.9 (oshio Funyu, MD, )36.8 (Y)99.8 (asuhiko Hirabayashi, MD,)]TJ
0.0005 Tc 0.3744 Tw 0 -1.25 TD
[(T)69.9 (omonori Ishii, MD, Kyoko Kaneda, MD, )36.7 (Y)99.9 (asumichi Kinoshita, MD,)]TJ
-0.00011 Tc 0.0981 Tw T*
[(Kuniaki Matsui, MD, Masashi Mikami, MD, Norio Mitomo, MD, )17.7 (T)69.9 (erunori)]TJ
0.127 Tw T*
(Murata, MD, Noburo Nomura, MD, Naoe Okabe, MD, Hiroshi Sato, MD,)Tj
0.0401 Tw T*
[(Isao Sato, MD, Jo Satoh, MD, )36.8 (Y)110.8 (ukio Sekiguchi, MD, Shinobu Shibata, MD,)]TJ
0.2403 Tw T*
[(Atsuo Suzuki, MD, )17.8 (T)69.9 (akashiro Suzuki, MD, )36.8 (Y)99.8 (oshio )17.8 (T)69.9 (aguma, MD, Eiichi)]TJ
0.02499 Tw T*
[(T)69.9 (amate, MD, and Hiroshi Unakami, MD.)]TJ
/T1_1 1 Tf
0 Tw 9.7 0 0 10 54 630.5293 Tm
(REFERENCES)Tj
/T1_0 1 Tf
0.02499 Tw 7.76 0 0 8 61.18 620.5293 Tm
[(1.)-515.6 (Levy JA, Ibrahim )54.8 (AB, Shirai )17.7 (T)74 (, et al. Dietary fat af)17.7 (fects immune)]TJ
1.2655 -1.25 Td
(response, production of antiviral factors, and immune complex disease)Tj
T*
[(in NZB/NZW)-257.3 (mice. Proc Natl )54.8 (Acad Sci USA)-220.2 (1982;79:1974-8.)]TJ
-1.2655 -1.25 Td
[(2.)-515.6 (Prickett JD, Robinson DR, Steinber)17.7 (g )54.8 (AD. Ef)17.7 (fects of dietary enrich-)]TJ
1.2655 -1.25 Td
(ment with eicosapentaenoic acid upon autoimmune nephritis in female)Tj
0 Tw T*
(NZBxNZW/F)Tj
0 Tc 5.04 0 0 5.2 114.5345 567.8893 Tm
(1)Tj
-0.00011 Tc 0.02499 Tw 7.76 0 0 8 119.1905 570.5293 Tm
[(mice. )54.8 (Arthritis Rheum 1983;26:133-9.)]TJ
-7.4756 -1.25 Td
[(3.)-515.6 (Dubois EL, Strain L. Ef)17.7 (fect of diet on survival and nephropathy of)]TJ
1.2655 -1.25 Td
[(NZB/NZW)-257.3 (hybrid mice. Biochem Med 1973;7:336-42.)]TJ
-1.2655 -1.25 Td
[(4.)-515.6 (Corman LC. )17.7 (The role of diet in animal models of systemic lupus)]TJ
1.2655 -1.25 Td
[(erythematosus: possible implications for human lupus. Semin )54.8 (Arthritis)]TJ
0 Tc T*
(Rheum 1985;15:61-9.)Tj
-0.00011 Tc -1.2655 -1.225 Td
[(5.)-515.6 (Brown )54.8 (AC. Lupus erythematosus and nutrition: a review of the)]TJ
1.2655 -1.225 Td
(literature. J Ren Nutr 2000;10:170-83.)Tj
-1.2655 -1.225 Td
[(6.)-515.6 (Clark )17.6 (WF)79.7 (, Parbtani )54.7 (A, Huf)17.7 (f MW)91.7 (, Reid B, Holub BJ, Falardeau P)110.7 (.)]TJ
1.2655 -1.225 Td
(Omega-3 fatty acid dietary supplementation in systemic lupus)Tj
0 -1.225 TD
(erythematosus. Kidney Int 1989;36:653-60.)Tj
-1.2655 -1.225 Td
[(7.)-515.6 (Thorner )54.8 (A, )17.7 (W)79.9 (alldius G, Nilsson E, Hadell K, Gullber)17.7 (g R. Beneficial)]TJ
1.2655 -1.225 Td
[(ef)17.7 (fects of reduced intake of polyunsaturated fatty acids in the diet for)]TJ
T*
[(one year in patients with systemic lupus erythematosus. )54.8 (Ann Rheum)]TJ
0 Tc T*
(Dis 1990;49:134.)Tj
-0.00011 Tc -1.2655 -1.225 Td
[(8.)-515.6 (W)79.9 (alton )54.8 (AJE, Snaith ML, Locniskar M, Cumberland )54.8 (AG, Morrow)]TJ
1.2655 -1.225 Td
[(WJW)91.7 (, Isenber)17.7 (g DA. Dietary fish oil and the severity of symptoms in)]TJ
T*
[(patients with systemic lupus erythematosus. )54.8 (Ann Rheum Dis)]TJ
0 Tc 0 Tw T*
(1991;50:463-6.)Tj
-0.00011 Tc 0.02499 Tw -1.2655 -1.225 Td
[(9.)-515.6 (Clark )17.7 (WF)79.7 (, Parbtani )54.8 (A, Naylor CD, et al. Fish oil in lupus nephritis:)]TJ
1.2655 -1.225 Td
(clinical findings and methodological implications. Kidney Int)Tj
0 Tc 0 Tw T*
(1993;44:75-86.)Tj
-0.00011 Tc 0.02499 Tw -1.7655 -1.25 Td
[(10.)-515.6 (Minami )36.8 (Y)128.9 (, Sasaki )17.7 (T)74 (, Komatsu S, et al. Female systemic lupus)]TJ
1.7655 -1.25 Td
[(erythematosus in Miyagi Prefecture, Japan: )54.8 (A)-220.1 (case-control study of)]TJ
0 -1.25 TD
[(dietary and reproductive factors. )17.7 (T)69.9 (ohoku J Exp Med 1993;169:245-52.)]TJ
-1.7286 -1.25 Td
[(1)36.8 (1)-0.1 (.)-515.6 (Comstock GW)91.7 (, Burke )54.8 (AE, Hof)17.7 (fman SC, et al. Serum concentration of)]TJ
/T1_2 1 Tf
0 Tc 0 Tw 1.7286 -1.25 Td
(\004)Tj
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 0.9059 0 Td
(tocopherol, \247 carotene, and retinol preceding the diagnosis of)Tj
-0.9059 -1.25 Td
[(rheumatoid arthritis and systemic lupus erythematosus. )54.8 (Ann Rheum)]TJ
T*
(Dis 1997;56:323-5.)Tj
-1.7655 -1.25 Td
[(12.)-515.6 (T)69.9 (an EM, Cohen )54.8 (AS, Fries JF)79.7 (, et al. )17.7 (The 1982 revised criteria for the)]TJ
1.7655 -1.25 Td
[(classification of systemic lupus erythematosus. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1982;25:1271-7.)Tj
-0.00011 Tc 0.02499 Tw -1.7655 -1.25 Td
[(13.)-515.6 (W)39.8 (illett )17.7 (W)91.9 (. Nutritional epidemiology)64.8 (. New )36.8 (Y)99.8 (ork: Oxford University)]TJ
1.7655 -1.25 Td
(Press; 1990.)Tj
-1.7655 -1.25 Td
[(14.)-515.6 (Shimizu H, Ohwaki )54.8 (A, Kurisu )36.8 (Y)128.9 (, et al. )17.7 (V)110.8 (alidity and reproducibility of a)]TJ
1.7655 -1.25 Td
(quantitative food frequency questionnaire for a cohort study in Japan.)Tj
T*
[(Jpn J Clin Oncol)-275.1 (1999;29:38-44.)]TJ
-1.7655 -1.25 Td
[(15.)-515.6 (Resources Council, Science and )17.7 (T)69.9 (echnology )54.8 (Agency)64.8 (, Japan. Standard)]TJ
1.7655 -1.25 Td
[(tables of food composition in Japan. 4th rev ed. )17.7 (T)69.9 (okyo: Department of)]TJ
T*
(Printing, Japanese Ministry of Finance; 1982.)Tj
-1.7655 -1.25 Td
[(16.)-515.6 (Urowitz MB, Gladman DD, )17.7 (T)69.9 (ozman ECS, Goldsmith CH. )17.7 (The Lupus)]TJ
1.7655 -1.25 Td
[(Activity Criteria Count. J Rheumatol 1984;1)36.8 (1:783-7.)]TJ
-1.7655 -1.25 Td
[(17.)-515.6 (Strand )17.7 (V)128.9 (, Gladman D, Isenber)17.7 (g D, Petri M, Smolen J, )17.7 (T)35 (ugwell P)110.7 (.)]TJ
1.7655 -1.25 Td
(Outcome measures to be used in clinical trials in systemic lupus)Tj
T*
(erythematosus. J Rheumatol 1999;26:490-7.)Tj
-1.7655 -1.25 Td
[(18.)-515.6 (Gladman D, Ginzler E, Goldsmith C, et al. )17.7 (The development and)]TJ
1.7655 -1.25 Td
(initial validation of the Systemic Lupus International Collaborating)Tj
T*
(Clinics/American College of Rheumatology damage index for)Tj
T*
[(systemic lupus erythematosus. )54.8 (Arthritis Rheum 1996;39:363-9.)]TJ
32.2552 77.6 Td
[(19.)-515.6 (Cox DR. Regression models and life tables. J Roy Stat Soc B)]TJ
0 Tc 0 Tw 1.7655 -1.25 Td
(1972;34:187-220.)Tj
-0.00011 Tc 0.02499 Tw -1.7655 -1.25 Td
[(20.)-515.6 (Miller RG. Simultaneous statistical inference. New )36.8 (Y)99.8 (ork: Springer)]TJ
1.7655 -1.25 Td
[(V)110.8 (erlag; 1981.)]TJ
-1.7655 -1.25 Td
[(21.)-515.6 (Rothman KJ, Greenland S. Modern epidemiology)64.8 (. 2nd ed.)]TJ
1.7655 -1.25 Td
(Philadelphia: Lippincott-Raven Publishers; 1998.)Tj
-1.7655 -1.25 Td
[(22.)-515.6 (Rosner B. Fundamentals of biostatistics. 4th ed. Belmont: Duxbury)]TJ
1.7655 -1.25 Td
(Press; 1995.)Tj
-1.7655 -1.25 Td
[(23.)-515.6 (SAS/ST)79.7 (A)110.8 (T)-257.1 (User)-37 (\325)55.1 (s guide, release 6.03. Cary)64.8 (, NC: SAS Institute Inc;)]TJ
0 Tc 0 Tw 1.7655 -1.25 Td
(1988.)Tj
-0.00011 Tc 0.02499 Tw -1.7655 -1.25 Td
[(24.)-515.6 (Kubo C, Johnson BC, Day NK, Good RA. Calorie source, calorie)]TJ
1.7655 -1.25 Td
(restriction, immunity and aging of \(NZB/NZW\)F)Tj
0 Tc 0 Tw 5.04 0 0 5.2 488.9707 601.8893 Tm
(1)Tj
-0.00011 Tc 0.02499 Tw 7.76 0 0 8 493.6267 604.5293 Tm
(mice. J Nutr)Tj
0 Tc 0 Tw -20.4416 -1.25 Td
[(1984;1)36.9 (14:1884-99.)]TJ
-0.00011 Tc 0.02499 Tw -1.7655 -1.25 Td
[(25.)-515.6 (Loh HS. )17.7 (The relationship between dietary ascorbic acid intake and)]TJ
1.7655 -1.25 Td
[(buf)17.7 (fy coat and plasma ascorbic acid concentrations at dif)17.7 (ferent ages.)]TJ
T*
[(Int J )17.7 (V)59.8 (itam Nutr Res 1972;42:80-5.)]TJ
-1.7655 -1.25 Td
[(26.)-515.6 (Kubena KS, McMurray DN. Nutrition and the immune system: a)]TJ
1.7655 -1.25 Td
[(review of nutrient-nutrient interactions. J )54.8 (Am Diet )54.8 (Assoc)]TJ
0 Tc 0 Tw T*
[(1996;96:1)36.9 (156-64.)]TJ
-0.00011 Tc 0.02499 Tw -1.7655 -1.25 Td
[(27.)-515.6 (Grimble RF)79.7 (. Ef)17.7 (fect of antioxidative vitamins on immune function with)]TJ
1.7655 -1.25 Td
[(clinical applications. Int J )17.7 (V)59.8 (itam Nutr Res 1997;67:312-20.)]TJ
-1.7655 -1.25 Td
[(28.)-515.6 (Jiang X, Chen F)79.7 (.)-0.1 ( )17.7 (The ef)17.7 (fect of lipid peroxides and superoxide)]TJ
1.7655 -1.25 Td
[(dismutase on systemic lupus erythematosus: a preliminary study)64.8 (. Clin)]TJ
T*
(Immunol Immunopathol 1992;63:39-44.)Tj
-1.7655 -1.25 Td
[(29.)-515.6 (Lunec J, Herbert K, Blount S, Grif)17.7 (fiths HR, Emery P)110.7 (. 8-)]TJ
1.7655 -1.25 Td
[(Hydroxydeoxyguanosine. )54.8 (A)-220.1 (marker of oxidative DNA)-220.2 (damage in)]TJ
T*
(systemic lupus erythematosus. FEBS Lett 1994;348:131-8.)Tj
-1.7655 -1.25 Td
[(30.)-515.6 (Cooke MS, Evans MD, Podmore ID, et al. Novel repair action of)]TJ
1.7655 -1.25 Td
[(vitamin C upon in vivo oxidative DNA)-220.2 (damage. FEBS Lett)]TJ
0 Tc 0 Tw T*
(1998;439:363-7.)Tj
-0.00011 Tc 0.02499 Tw -1.7655 -1.25 Td
[(31.)-515.6 (Evans MD, Cooke MS, )54.8 (Akil M, Samanta )54.8 (A, Lunec J. )54.8 (Aberrant)]TJ
1.7655 -1.25 Td
[(processing of oxidative DNA)-220.2 (damage in systemic lupus erythematosus.)]TJ
0 Tc T*
(Biochem Biophys Res Commun 2000;273:894-8.)Tj
-0.00011 Tc -1.7655 -1.25 Td
[(32.)-515.6 (W)79.9 (eimann BJ, )17.7 (W)79.9 (eiser H. Ef)17.7 (fects of antioxidant vitamins C, E, and )]TJ
/T1_3 1 Tf
0 Tc 0 Tw 28.4197 0 Td
(\247)Tj
/T1_0 1 Tf
(-)Tj
-0.00011 Tc 0.02499 Tw -26.6542 -1.25 Td
[(carotene on immune functions in MRL/lpr mice and rats. )54.8 (Ann NY)]TJ
T*
(Acad Sci 1992;669:390-2.)Tj
-1.7655 -1.25 Td
[(33.)-515.6 (W)79.9 (einmann BJ, Hermann D. Inhibition of autoimmune deterioration in)]TJ
1.7655 -1.25 Td
[(MRL/lpr mice by vitamin E. Int J )17.7 (V)59.8 (itam Nutr Res 1999;69:255-61.)]TJ
-1.7655 -1.25 Td
[(34.)-515.6 (T)35 (rowell H. Definition of dietary fiber and hypotheses that it is a)]TJ
1.7655 -1.25 Td
[(protective factor in certain diseases. )54.8 (Am J Clin Nutr)-275.1 (1976;29:417-27.)]TJ
-1.7655 -1.25 Td
[(35.)-515.6 (Shigemasa C, )17.7 (T)69.9 (anaka )17.7 (T)74 (, Mashiba H. Ef)17.7 (fect of vegetarian diet on)]TJ
1.7655 -1.25 Td
[(systemic lupus erythematosus. Lancet 1992;339:1)36.8 (177.)]TJ
-1.7655 -1.25 Td
[(36.)-515.6 (Nakayama )17.7 (T)74 (, Date C, )36.8 (Y)99.8 (okoyama )17.7 (T)74 (,)-0.1 ( )36.7 (Y)99.8 (oshiike N, )36.8 (Y)99.8 (amaguchi M, )17.7 (T)69.9 (anaka)]TJ
1.7655 -1.25 Td
[(H. )54.8 (A)-220.1 (15.5-year follow-up study of stroke in a Japanese provincial city)64.9 (.)]TJ
T*
[(The Shibata Study)64.8 (. Stroke 1997;28:45-52.)]TJ
-1.7655 -1.25 Td
[(37.)-515.6 (Shimozato M, Nakayama )17.7 (T)74 (,)-0.1 ( )36.8 (Y)99.8 (okoyama )17.7 (T)74 (,)-0.1 ( )36.8 (Y)99.8 (oshiike N, )36.8 (Y)99.8 (amaguchi M,)]TJ
1.7655 -1.25 Td
[(Date C. )54.8 (A)-220.1 (15.5-year cohort study on risk factors for possible)]TJ
T*
(myocardial infarction and sudden death within 24 hours in a rural)Tj
T*
[(Japanese community)64.8 (. J Epidemiol 1996;6:15-22.)]TJ
-1.7655 -1.25 Td
[(38.)-515.6 (Petri M. Detection of coronary artery disease and the role of traditiona\
l)]TJ
1.7655 -1.25 Td
(risk factors in the Hopkins Lupus Cohort. Lupus 2000;9:170-5.)Tj
-1.7655 -1.25 Td
[(39.)-515.6 (Fujishima M, Kiyohara )36.8 (Y)128.9 (, Kato I, et al. Diabetes and cardiovascular)]TJ
1.7655 -1.25 Td
[(disease in a prospective population survey in Japan. )17.7 (The Hisayama)]TJ
T*
[(Study)64.8 (. Diabetes 1996;45 Suppl 3:S14-6.)]TJ
-1.7655 -1.25 Td
[(40.)-515.6 (Hu FB, Manson JE, )17.7 (W)39.8 (illett )17.7 (WC. )17.7 (T)69.9 (ypes of dietary fat and risk of)]TJ
1.7655 -1.25 Td
[(coronary heart disease: a critical review)64.8 (. J )54.8 (Am Coll Nutr 2001;20:5-19.)]TJ
-1.7655 -1.25 Td
[(41.)-515.6 (Petri M, Roubenof)17.7 (f R, Dallal GE, Nadeau MR, Selhub J, Rosenber)17.7 (g)]TJ
1.7655 -1.25 Td
(IH. Plasma homocysteine as a risk factor for atherothrombotic events)Tj
T*
[(in systemic lupus erythematosus. Lancet 1996;348:1)36.8 (120-4.)]TJ
ET
0 0 0 0 scn
440 777 117 -27 re
f*
BT
0 0 0 1 scn
/T1_4 1 Tf
0 Tw 20.37 0 0 21 441 760.6089 Tm
(\002\003\003\002\004\005\006\007\004\006)Tj
ET
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
/T1_3 1 Tf
0.02499 Tw 8 0 0 8 424.3613 35.9844 Tm
(The Journal of Rheumatology 2003; 30:4)Tj
0 Tc 0 Tw -46.2952 -0.0313 Td
(754)Tj
ET
0 0 0 0 scn
/GS0 gs
109.25 59.1 396.47 -10.84 re
f*
0.5 w
109.25 59.1 396.47 -10.84 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_5 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_6 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
58 0 obj
<>
endobj
22 0 obj
<>
endobj
23 0 obj
<>
endobj
49 0 obj
<>
endobj
50 0 obj
<>
endobj
86 0 obj
<>
endobj
108 0 obj
<>
endobj
52 0 obj
<>
endobj
54 0 obj
<>
endobj
51 0 obj
<>stream
H\Mk0:vYk]ȡi`e8C7G0C=ũ=b!t/5lN|!g]R&KC'mws240qܼy~biq~GNG
yN/o9pfԘ+álbmpRl r\tȅ.(K
Rk9Y-
[d)^A pBbkY"!vȝ FfGbKlRK-AZ:GT*H}{ Q>j($ QHTaVPHPA PA#
R|Tq}
R*h9p
@fI}T©ۺ|6taq|q{1M|A2!G6O3͇ X$
endstream
endobj
53 0 obj
<>stream
H\{PSC%BwMHJlZ'ĝ8I/Y*n%p.Yٴ :lCvP1 (LP 8# `= )8l ?'@NK 9wҲDJeRўӳ%t-mȲ+ s|UBAbMkڷl*=ǂqZ>UrHk%Sk)CIg~\,^]d
CE#DiVʫuO6?&@cS90Kup}_4jri|okQHWlٶlۙNA5īEjy.F:mK%||}m#p]U^8 cտ2H{P6ԛ'VqsFmJKH1zo laxPRX776&E#-y,.gƆW8sɡγ2LhJ 4_TF@qFfzޤ
QI2BYTr90[HH+`*ؤIR}^Ej\Gs ~.0R{RUQ.R
$
UgHXZ6F9]sK3)VkͨU۪k+h_T{aAtKؐgSi_YL$:iCB\݁)DELt^$M%7{lGu+W սu!Ф8\}\Q1a=/%d.7/9p)a|Kݯi'\y|4k 7śBk# ɇv|2`{I
ēǏ)zkmr {87D7EYxxnLZ$ΒzXol*OgC1&?\Mg"g#A_m1X/o.R#MۮFϕgT#gd=ê
JL263 yBm@&wШų4CI֊{b0@LK~>Vc$BTYXL:aE;\w\^};ZX\-(+"Zl `~W#?Y3ѻ<7:3
)fUhV`[eӷ@SxTPP;W)s\ȔRx~>@GPFX.6^Aiz+2Дzr
#t] <-VFF! \N^u-U.}YwZv:>{_uIN!PY SQ#b3..
3J1*ΥUn¡dmMzr8=e#*%